Evenity manufacturer?

Evenity (romosozumab) is manufactured and marketed in the United States by Amgen Inc.

• Developer / Manufacturer: Amgen (with co‑development by Genentech/Roche).
• Approval status: FDA‑approved for osteoporosis in post‑menopausal women and men at high risk of fracture (2020).
• Global distribution: In most other regions, the drug is marketed under Roche/Genentech.

If you have more specific questions—such as dosage, indications, or availability—feel free to ask!